UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 128

Sortiert nach

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China

International journal of infectious diseases, 2020-02, Vol.91, p.264-266

2020

Link zum Volltext

Verfügbarkeit prüfen

Whole genome sequencing and prediction of antimicrobial susceptibilities in non-tuberculous mycobacteria

Frontiers in microbiology, 2022-11, Vol.13, p.1044515-1044515

2022

Link zum Volltext

Verfügbarkeit prüfen

Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution

BMC microbiology, 2020-08, Vol.20 (1), p.271-271, Article 271

2020

Link zum Volltext

Verfügbarkeit prüfen

Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis

Scientific reports, 2022-12, Vol.12 (1), p.21429-21429

2022

Link zum Volltext

Verfügbarkeit prüfen

Detection and characterization of carbapenem resistant Gram-negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan

BMC microbiology, 2021-05, Vol.21 (1), p.136-136, Article 136

2021

Link zum Volltext

Verfügbarkeit prüfen

Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition

Scientific reports, 2018-01, Vol.8 (1), p.1150-7, Article 1150

2018

Link zum Volltext

Verfügbarkeit prüfen

Profiling and identification of novel rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Pakistan

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021-11, Vol.27 (11), p.1578-1583

2021

Link zum Volltext

Verfügbarkeit prüfen

Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR

Frontiers in immunology, 2021-03, Vol.11, p.612564-612564

2021

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis: advances and challenges in development of new diagnostics and biomarkers

The Lancet infectious diseases, 2018-07, Vol.18 (7), p.e199-e210

2018

Link zum Volltext

Verfügbarkeit prüfen

Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model

Antibiotics (Basel), 2021-12, Vol.10 (12), p.1515

2021

Link zum Volltext

Verfügbarkeit prüfen

Reducing the risk of tuberculosis transmission for HCWs in high incidence settings

Antimicrobial resistance & infection control, 2021-07, Vol.10 (1), p.1-106, Article 106

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Molecular Typing of Acinetobacter baumannii in Comparison with Orthogonal Methods

Microbiology spectrum, 2023-06, Vol.11 (3), p.e0499522-e0499522

2023

Link zum Volltext

Verfügbarkeit prüfen

Chloroform extract of turmeric inhibits biofilm formation, EPS production and motility in antibiotic resistant bacteria

The Journal of General and Applied Microbiology, 2017, Vol.63(6), pp.325-338

2017

Link zum Volltext

Verfügbarkeit prüfen

Application of Bacteriophages for Mycobacterial Infections, from Diagnosis to Treatment

Microorganisms (Basel), 2021-11, Vol.9 (11), p.2366

2021

Link zum Volltext

Verfügbarkeit prüfen

An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis

International journal of antimicrobial agents, 2012-02, Vol.39 (2), p.124-129

2012

Link zum Volltext

Verfügbarkeit prüfen

Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid

PLOS global public health, 2023-10, Vol.3 (10), p.e0002283-e0002283

2023

Link zum Volltext

Verfügbarkeit prüfen

Pre-Clinical Tools for Predicting Drug Efficacy in Treatment of Tuberculosis

Microorganisms (Basel), 2022-02, Vol.10 (3), p.514

2022

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

The Lancet infectious diseases, 2018-07, Vol.18 (7), p.e183-e198

2018

Link zum Volltext

Verfügbarkeit prüfen

DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities

Journal of antibiotics, 2016-12, Vol.69 (12), p.843-849

2016

Link zum Volltext

Verfügbarkeit prüfen

A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Nucleic Acid Amplification Tests for Tuberculous Meningitis

Journal of clinical microbiology, 2019-06, Vol.57 (6)

2019

Link zum Volltext

Verfügbarkeit prüfen

Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions

PLOS global public health, 2023-01, Vol.3 (11), p.e0002159-e0002159

2023

Link zum Volltext

Verfügbarkeit prüfen

Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development

Microorganisms (Basel), 2022-02, Vol.10 (2), p.460

2022

Link zum Volltext

Verfügbarkeit prüfen

Zoonotic disease preparedness in sub-Saharan African countries

One health outlook, 2021-03, Vol.3 (1), p.5-5, Article 5

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the beta-ketoacyl-ACP synthase mtFabH

PloS one, 2009-05, Vol.4 (5), p.e5617-e5617

2009

Link zum Volltext

Verfügbarkeit prüfen

2-Hydroxy-substituted cinnamic acids and acetanilides are selective growth inhibitors of Mycobacterium tuberculosis

MedChemComm, 2014-01, Vol.5 (1), p.47-50

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 128

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(57)
Microbiology
(28)
Tuberculosis
(26)
Infectious Diseases
(24)
Drug Resistance
(19)
Mycobacterium Tuberculosis
(16)
Pharmacology & Pharmacy
(16)
Antibiotics
(15)
Infections
(11)
Animals
(10)
Bacteria
(10)
Mycobacterium Tuberculosis - Drug Effects
(9)
Biological And Medical Sciences
(8)
Drug Development
(8)
Laboratories
(8)
Medical Sciences
(8)
Microbial Sensitivity Tests
(8)
Physical Sciences
(8)
Antitubercular Agents - Pharmacology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China

Whole genome sequencing and prediction of antimicrobial susceptibilities in non-tuberculous mycobacteria

Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution

Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis

Detection and characterization of carbapenem resistant Gram-negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan

Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition

Profiling and identification of novel rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Pakistan

Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR

Tuberculosis: advances and challenges in development of new diagnostics and biomarkers

Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model

Reducing the risk of tuberculosis transmission for HCWs in high incidence settings

Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Molecular Typing of Acinetobacter baumannii in Comparison with Orthogonal Methods

Chloroform extract of turmeric inhibits biofilm formation, EPS production and motility in antibiotic resistant bacteria

Application of Bacteriophages for Mycobacterial Infections, from Diagnosis to Treatment

An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis

Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid

Pre-Clinical Tools for Predicting Drug Efficacy in Treatment of Tuberculosis

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities

A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Nucleic Acid Amplification Tests for Tuberculous Meningitis

Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions

Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development

Zoonotic disease preparedness in sub-Saharan African countries

Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the beta-ketoacyl-ACP synthase mtFabH

2-Hydroxy-substituted cinnamic acids and acetanilides are selective growth inhibitors of Mycobacterium tuberculosis

Aktive Filter

Suchergebnisse filtern